{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T18:01:36Z","timestamp":1790100096511,"version":"4.0.1"},"reference-count":46,"publisher":"American Academy of Pediatrics (AAP)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,10,1]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>BACKGROUND AND OBJECTIVES<\/jats:title>\n                    <jats:p>HIV preexposure prophylaxis (PrEP) is a safe and effective way to reduce HIV acquisition and was approved for adolescents in 2018. We assessed whether states with minor consent laws (MCLs) allowing younger adolescents to receive PrEP without parental\/guardian consent were associated with increased prescription fills.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>METHODS<\/jats:title>\n                    <jats:p>A legal review classified whether states had MCLs. A negative binomial regression model using national all-payer pharmacy claims compared PrEP fills between minors (13\u201317\u00a0years) and majority-age adolescents (18\u201319\u00a0years) between states with and without MCLs from 2015 to 2021, among 15 states with the highest minor PrEP fills. Key informant interviews (n\u2009=\u200925 experts from 7 states) elicited context for interpreting statistical results.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS<\/jats:title>\n                    <jats:p>On average, minors had lower PrEP fills than majority-age adolescents (incident rate ratio [IRR],\u20090.21; 95% CI, 0.17\u20130.24). However, the interaction term between MCL and age group was insignificant (IRR,\u20091.11; 95% CI, 0.91\u20131.36), indicating that age group differences were similar between MCL and non-MCL states. Experts described numerous barriers faced by adolescents in accessing PrEP, including confidentiality concerns, clinic access, stigma, providers\u2019 hesitancy to discuss sexual health with and prescribe PrEP to minors, limited information on PrEP in school-based sexual education, and health care literacy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSIONS<\/jats:title>\n                    <jats:p>We did not find evidence that the gap in PrEP prescription fills between minor and majority-age adolescents was smaller among states with PrEP-inclusive MCLs. Strategies to address the numerous barriers in PrEP access experienced by adolescents may be needed.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1542\/peds.2024-069808","type":"journal-article","created":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T00:02:51Z","timestamp":1758240171000},"source":"Crossref","is-referenced-by-count":3,"title":["HIV Preexposure Prophylaxis Prescriptions, Consent Laws, and Uptake Barriers Among Adolescents"],"prefix":"10.1542","volume":"156","author":[{"given":"Erika G.","family":"Martin","sequence":"first","affiliation":[{"name":"1Department of Public Administration and Policy, Rockefeller College of Public Affairs and Policy, University at Albany, Albany, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Montserrat","family":"Avila Acosta","sequence":"additional","affiliation":[{"name":"1Department of Public Administration and Policy, Rockefeller College of Public Affairs and Policy, University at Albany, Albany, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dawn A.","family":"Pepin","sequence":"additional","affiliation":[{"name":"2Program Performance Improvement Office, Office of the Director, National Center for HIV, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya-lin A.","family":"Huang","sequence":"additional","affiliation":[{"name":"3Division of HIV Prevention, National Center for HIV, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiming","family":"Zhu","sequence":"additional","affiliation":[{"name":"3Division of HIV Prevention, National Center for HIV, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rupa R.","family":"Patel","sequence":"additional","affiliation":[{"name":"3Division of HIV Prevention, National Center for HIV, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen W.","family":"Hoover","sequence":"additional","affiliation":[{"name":"3Division of HIV Prevention, National Center for HIV, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"417","published-online":{"date-parts":[[2025,9,19]]},"reference":[{"key":"2026052212414667800_r1","article-title":"HIV surveillance report: diagnoses, deaths, and prevalence of HIV in the United States and 6 territories and freely associated states, 2022","author":"Centers for Disease Control and Prevention","year":"2024"},{"key":"2026052212414667800_r2","article-title":"Preexposure prophylaxis for the prevention of HIV infection in the United States - 2021 update","author":"Centers for Disease Control and Prevention","year":"2021"},{"issue":"RR-3","key":"2026052212414667800_r3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr6903a1","article-title":"Preexposure prophylaxis for prevention of HIV acquistion among adolescents: Clinical considerations, 2020","volume":"69","author":"Tanner","year":"2020","journal-title":"MMWR Recomm Rep."},{"issue":"4","key":"2026052212414667800_r4","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.jadohealth.2018.07.021","article-title":"HIV pre-exposure prophylaxis medication for adolescents and young adults: a position paper of the Society for Adolescent Health and Medicine","volume":"63","author":"Society for Adolescent Health and Medicine","year":"2018","journal-title":"J Adolesc Health."},{"issue":"1","key":"2026052212414667800_r5","doi-asserted-by":"crossref","first-page":"e2021055207","DOI":"10.1542\/peds.2021-055207","article-title":"Adolescents and young adults: the pediatrician\u2019s role in HIV testing and pre- and postexposure HIV prophylaxis","volume":"149","author":"Hsu","year":"2022","journal-title":"Pediatrics."},{"issue":"1","key":"2026052212414667800_r6","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1097\/PHH.0000000000001833","article-title":"A narrative review of literature examining studies researching the impact of law on health and economic outcomes","volume":"30","author":"Pepin","year":"2024","journal-title":"J Public Health Manag Pract."},{"issue":"7","key":"2026052212414667800_r7","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1001\/jama.2022.10777","article-title":"Minor consent laws for sexually transmitted infection and HIV services","volume":"328","author":"Nelson","year":"2022","journal-title":"JAMA."},{"issue":"1","key":"2026052212414667800_r8","doi-asserted-by":"crossref","first-page":"S119","DOI":"10.1016\/j.amepre.2012.09.044","article-title":"State adolescent consent laws and implications for HIV pre-exposure prophylaxis","volume":"44","author":"Culp","year":"2013","journal-title":"Am J Prev Med."},{"key":"2026052212414667800_r9","volume-title":"State Minor Consent Laws: A Summary","author":"Center for Adolescent Health & the Law","year":"2010","edition":"3rd ed"},{"issue":"4","key":"2026052212414667800_r10","doi-asserted-by":"crossref","first-page":"397","DOI":"10.2105\/AJPH.2022.307199","article-title":"Minor consent laws for sexually transmitted infection and human immunodeficiency virus services in the United States: a comprehensive, longitudinal study of US state laws","volume":"113","author":"Nelson","year":"2023","journal-title":"Am J Public Health."},{"key":"2026052212414667800_r11","article-title":"Preexposure prophylaxis for the prevention of HIV infection \u2013 2014: clinical providers\u2019 supplement","author":"Smith","year":"2014"},{"issue":"2","key":"2026052212414667800_r12","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1093\/cid\/ciw701","article-title":"Uptake of HIV preexposure prophylaxis among commercially insured persons-United States, 2010\u20132014","volume":"64","author":"Wu","year":"2017","journal-title":"Clin Infect Dis."},{"issue":"5","key":"2026052212414667800_r13","doi-asserted-by":"crossref","first-page":"e2023062599","DOI":"10.1542\/peds.2023-062599","article-title":"HIV preexposure prophylaxis provision among adolescents: 2018 to 2021","volume":"152","author":"Kimball","year":"2023","journal-title":"Pediatrics."},{"issue":"41","key":"2026052212414667800_r14","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.15585\/mmwr.mm6741a3","article-title":"HIV preexposure prophylaxis, by race and ethnicity - United States, 2014\u20132016","volume":"67","author":"Huang","year":"2018","journal-title":"MMWR Morb Mortal Wkly Rep."},{"issue":"2","key":"2026052212414667800_r15","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1177\/0033354920904085","article-title":"Evaluation of algorithms used for PrEP surveillance using a reference population from New York City, July 2016-June 2018","volume":"135","author":"Furukawa","year":"2020","journal-title":"Public Health Rep."},{"key":"2026052212414667800_r16","article-title":"National Center for HIV, Viral Hepatitis, STD, and Tuberculosis Prevention","author":"Centers for Disease Control and Prevention"},{"key":"2026052212414667800_r17","article-title":"Dicennial Census P12: sex by age for selected age categories","author":"US Census Bureau"},{"key":"2026052212414667800_r18","doi-asserted-by":"crossref","DOI":"10.4135\/9781452230153","volume-title":"Basics of Qualitative Research: Techniques and Procedures for Developing Grounded Theory","author":"Corbin","year":"2008","edition":"3rd ed"},{"key":"2026052212414667800_r19","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-319-69909-7_3470-2","volume-title":"Thematic Analysis: A Practical Guide","author":"Braun","year":"2022"},{"key":"2026052212414667800_r20","article-title":"Ending the HIV epidemic in the US (EHE)","author":"Centers for Disease Control and Prevention","year":"2024"},{"issue":"4","key":"2026052212414667800_r21","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1097\/MOP.0000000000001357","article-title":"HIV preexposure prophylaxis in adolescents and young adults: an update","volume":"36","author":"Camfield","year":"2024","journal-title":"Curr Opin Pediatr."},{"key":"2026052212414667800_r22","article-title":"National sex education standards: core content and skills, K-12 (second edition)","author":"Future of Sex Education Initiative","year":"2020"},{"key":"2026052212414667800_r23","article-title":"School health profiles explorer","author":"Centers for Disease Control and Prevention","year":"2022"},{"issue":"3","key":"2026052212414667800_r24","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1097\/QAI.0000000000002954","article-title":"A pilot study of a patient navigation intervention to improve HIV preexposure prophylaxis persistence among Black\/African American men who have sex with men","volume":"90","author":"Goedel","year":"2022","journal-title":"J Acquir Immune Defic Syndr."},{"issue":"2","key":"2026052212414667800_r25","doi-asserted-by":"crossref","first-page":"e114","DOI":"10.1016\/S2352-3018(20)30256-3","article-title":"Same-day prescribing of daily oral pre-exposure prophylaxis for HIV prevention","volume":"8","author":"Rowan","year":"2021","journal-title":"Lancet HIV."},{"issue":"6S","key":"2026052212414667800_r26","doi-asserted-by":"crossref","first-page":"S26","DOI":"10.1016\/j.jadohealth.2023.09.002","article-title":"Same-day initiation of oral pre-exposure prophylaxis is high among adolescent men who have sex with men and transgender women in Brazil","volume":"73","author":"Soares","year":"2023","journal-title":"J Adolesc Health."},{"key":"2026052212414667800_r27","volume-title":"Technical Brief","author":"World Health Organization","year":"2022"},{"issue":"5","key":"2026052212414667800_r28","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1097\/QAI.0000000000003375","article-title":"Effectiveness of PrEPTECH: findings from a 180-day randomized controlled trial of a pre-exposure prophylaxis telehealth intervention","volume":"95","author":"Erenrich","year":"2024","journal-title":"J Acquir Immune Defic Syndr."},{"key":"2026052212414667800_r29","doi-asserted-by":"crossref","first-page":"23259582231215882","DOI":"10.1177\/23259582231215882","article-title":"\u201cPharmacies are everywhere, and you can get it at any time\u201d: experiences with pharmacy-based PrEP delivery among adolescent girls and young women in Kisumu, Kenya","volume":"22","author":"Vera","year":"2023","journal-title":"J Int Assoc Provid AIDS Care."},{"issue":"5","key":"2026052212414667800_r30","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1007\/s10461-021-03494-4","article-title":"Pharmacy-based interventions to increase use of HIV pre-exposure prophylaxis in the United States: a scoping review","volume":"26","author":"Zhao","year":"2022","journal-title":"AIDS Behav."},{"issue":"12","key":"2026052212414667800_r31","doi-asserted-by":"crossref","first-page":"e009474","DOI":"10.1136\/bmjgh-2022-009474","article-title":"Interventions to increase the uptake and continuation of pre-exposure prophylaxis (PrEP) by adolescent girls and young women at high risk of HIV in low-income and middle-income countries: a scoping review","volume":"7","author":"Ekwunife","year":"2022","journal-title":"BMJ Glob Health."},{"issue":"4","key":"2026052212414667800_r32","doi-asserted-by":"crossref","first-page":"e25561","DOI":"10.2196\/25561","article-title":"A mobile phone app to support adherence to daily HIV pre-exposure prophylaxis engagement among younger men who have sex with men and transgender women aged 15 to 19\u00a0years in Thailand: pilot randomized controlled trial","volume":"10","author":"Kawichai","year":"2022","journal-title":"JMIR Mhealth Uhealth."},{"key":"2026052212414667800_r33","volume-title":"Persistence in care after PrEP initiation through a community-based mobile clinic.","author":"Doblecki-Lewis","year":"2024"},{"key":"2026052212414667800_r34","volume-title":"Early implementation experience and lessons learned from eight diverse clinics introducing long-acting injectables for HIV treatment.","author":"Meyers","year":"2024"},{"issue":"2","key":"2026052212414667800_r35","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1007\/s11904-018-0385-0","article-title":"PrEP stigma: Implicit and explicit drivers of disparity","volume":"15","author":"Golub","year":"2018","journal-title":"Curr HIV\/AIDS Rep."},{"issue":"5","key":"2026052212414667800_r36","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1007\/s12325-020-01295-0","article-title":"Barriers to the wider use of pre-exposure prophylaxis in the United States: A narrative review","volume":"37","author":"Mayer","year":"2020","journal-title":"Adv Ther."},{"issue":"1","key":"2026052212414667800_r37","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1007\/s11524-022-00711-w","article-title":"The potential of long-acting, injectable PrEP, and impediments to its uptake","volume":"100","author":"Miller","year":"2023","journal-title":"J Urban Health."},{"issue":"6","key":"2026052212414667800_r38","doi-asserted-by":"crossref","first-page":"e177","DOI":"10.1016\/j.amepre.2019.01.011","article-title":"Association of state laws with influenza vaccination of hospital personnel","volume":"56","author":"Lindley","year":"2019","journal-title":"Am J Prev Med."},{"issue":"1","key":"2026052212414667800_r39","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1089\/heq.2021.0113","article-title":"Mapping nurse practitioners\u2019 scope of practice laws: a resource for evaluating pre-exposure prophylaxis prescriptions","volume":"6","author":"Salvant Valentine","year":"2022","journal-title":"Health Equity."},{"issue":"1","key":"2026052212414667800_r40","doi-asserted-by":"crossref","first-page":"6","DOI":"10.15585\/mmwr.mm6801a2","article-title":"Evaluation of state-mandated reporting of neonatal abstinence syndrome- Six states, 2013\u20132017","volume":"68","author":"Jilani","year":"2019","journal-title":"MMWR Morb Mortal Wkly Rep."},{"key":"2026052212414667800_r41","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.annepidem.2021.02.006","article-title":"Differences in rapid increases in county-level COVID-19 incidence by implementation of statewide closures and mask mandates- United States, June 1\u2013September 30, 2020","volume":"57","author":"Dasgupta","journal-title":"Ann Epidemiol."},{"issue":"2","key":"2026052212414667800_r42","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1002\/pam.21797","article-title":"Policy modeling to support administrative decisionmaking on the New York state HIV testing law","volume":"34","author":"Martin","year":"2015","journal-title":"J Policy Anal Manage."},{"issue":"3","key":"2026052212414667800_r43","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1093\/cid\/ciac009","article-title":"Abandonment of human immunodeficiency virus preexposure prophylaxis prescriptions at retail pharmacies\u2013United States, 2019","volume":"75","author":"Huang","year":"2022","journal-title":"Clin Infect Dis."},{"key":"2026052212414667800_r44","article-title":"Adolescent provider toolkit- Maryland minor consent laws","author":"Maryland Department of Health","year":"2012"},{"key":"2026052212414667800_r45","article-title":"[Dear provider letter on recent changes to Part 23 of New York Codes, Rules, and Regulations regarding the right of minors to consent for sexually transmitted disease and HIV prevention and treatment services]","author":"Morne","year":"2017"},{"key":"2026052212414667800_r46","article-title":"Frequently asked questions: guidance for local health departments (LHD) and health care providers on STI billing and minor\u2019s consent to prevention services and HIV-related services","author":"New York State Department of Health","year":"2019"}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/doi\/10.1542\/peds.2024-069808\/1849396\/pediatrics.2024069808.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/doi\/10.1542\/peds.2024-069808\/1849396\/pediatrics.2024069808.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T16:41:57Z","timestamp":1779468117000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/156\/4\/e2024069808\/203958\/HIV-Preexposure-Prophylaxis-Prescriptions-Consent"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,19]]},"references-count":46,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2025,9,19]]},"published-print":{"date-parts":[[2025,10,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.2024-069808","relation":{},"ISSN":["0031-4005","1098-4275"],"issn-type":[{"value":"0031-4005","type":"print"},{"value":"1098-4275","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,19]]},"article-number":"e2024069808"}}